Aqueous 1-butanol extracts were prepared from the ascites form of Gardner lymphosarcoma (LSG) maintained in C3H (H-2k) mice and from the solid Lewis lung carcinoma (LLCa) transplanted in B6 mice. C3H mice primed at least two times with cell surface antigens extracted from Gardner tumor cells (LSG-extract) lived longer than untreated controls if challenged with the solid Gardner lymphosarcoma cells. Tumors growing in immunized C3H mice differed from those growing in controls by shape, necrotization and inhibition of dissemination. If C3H mice were primed three times with LLCa extract then the survival was in comparison to intact controls prolonged only when the mice were pretreated into the site of tumor challenge. Survival time of B6 and B10 mice with transplanted LLCa was not markedly changed by previous priming injections of LSG-extract. An increase in mortality was recorded when LSG-extract-primed B10 mice were compared to the group of mice of the same line; similar effect has not been found in B6 mice.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gardner lymphosarcoma
16
c3h mice
12
mice
11
c3h h-2k
8
solid gardner
8
mice primed
8
b10 mice
8
c3h
5
immunogenicity gardner
4
lymphosarcoma
4

Similar Publications

Background: CAR T-cell therapy (CAR-T) is leading to durable responses in patients with cancer but there is concern that cytokine release syndrome (CRS) and neurotoxicity may impact survivors' cognitive function. We assessed long-term cognitive function in CAR-T recipients and examine factors associated with change in cognition over time.

Methods: We assessed perceived cognition (Functional Assessment of Cancer Therapy - Cognition) and neurocognitive performance (standardized neuropsychological battery) in adult patients prior to receiving CAR-T and at 6 month follow-up.

View Article and Find Full Text PDF

Cutaneous T cell lymphoma (CTCL) is a potentially fatal clonal malignancy of T cells primarily affecting the skin. The most common form of CTCL, mycosis fungoides, can be difficult to diagnose, resulting in treatment delay. We performed single-cell and spatial transcriptomics analysis of skin from patients with mycosis fungoides-type CTCL and an integrated comparative analysis with human skin cell atlas datasets from healthy and inflamed skin.

View Article and Find Full Text PDF

Background: Deleterious germline variants in and have been associated with a moderately increased risk of breast cancer. Risks for other cancers remain unclear.

Methods: Cancer associations for coding variants in and were evaluated using whole-exome sequence data from UK Biobank linked to cancer registration data (348 488 participants), and analysed both as a retrospective case-control and a prospective cohort study.

View Article and Find Full Text PDF

Deficiency of Adenosine Deaminase 2 (DADA2) patients presenting with primary immunodeficiency are at risk of uncontrolled EBV infection and secondary malignancies including EBV-related lymphoproliferative disorders (LPD). This paper describes the first case of EBV related diffuse large B-cell lymphoma in a patient with DADA2 and uncontrolled EBV infection. Consideration should be given to monitoring for EBV viraemia and to preventative EBV specific therapy in DADA2 and patients with at risk primary immunodeficiencies.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the safety and effectiveness of combining low-dose doxorubicin with a canine-specific anti-CD20 monoclonal antibody (1E4-cIgGB) in dogs with untreated B-cell lymphoma.
  • Forty-two dogs were enrolled, and results showed a significant decrease in CD21+ B-cells after treatment, with effects lasting over four months; however, T-cell counts remained stable.
  • The combination treatment was generally well-tolerated, with only one instance of hypersensitivity, suggesting that 1E4-cIgGB is a safe option for depleting B-cells in affected dogs.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!